[Featured Stock] Hancom Lifecare Rises on News of Putin Halting Participation in Nuclear Arms Reduction Treaty

[Asia Economy Reporter Jang Hyowon] Hancom Lifecare is showing strong performance. Following Russia's announcement to suspend participation in the nuclear arms reduction treaty, increasing the possibility of a nuclear attack, Hancom Lifecare, which produces potassium iodide pills that prevent the absorption of radioactive materials, is drawing attention.

As of 10:12 AM on the 22nd, Hancom Lifecare is trading at 6,180 KRW, up 4.39% compared to the previous day.

According to foreign media, Russian President Vladimir Putin declared on the 21st (local time) the suspension of participation in the New Strategic Arms Reduction Treaty (New START) with the United States.

In a state address at the Gostiny Dvor Exhibition Hall in Moscow, President Putin stated, "No one should be under the illusion that they can disrupt the global strategic balance," and announced, "Russia is suspending its participation in New START."

He added, "Russia was not allowed inspections under the treaty," and argued, "It is unreasonable for the West to demand that Russia allow inspections."

Furthermore, he said, "If the United States conducts nuclear tests, we will do the same," and instructed, "The Ministry of Defense and Rosatom (the state nuclear corporation) must prepare for this."

Hancom Lifecare manufactures various safety equipment and supplies such as air respirators, gas masks, and protective suits, focusing on public, defense, industrial, and daily life business sectors.

Regarding the threat of a nuclear attack from Russia, the stock price is rising amid expectations that Ukraine could secure potassium iodide pills that prevent the absorption of radioactive materials into the human body.

This content was produced with the assistance of AI translation services.